Search - tctmd.com

Displaying 481 - 500 of 748

Sort: Relevancy | Date

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Daily News

Los IAM secundarios a Embolismos Coronarios son Raros y Suelen Asociarse a la FA

L.A. McKeown

July 08, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Daily News

A Mayor Edad, Mayor Riesgo de Isquemia Cerebral Recurrente en Pacientes sometidos al Cierre del FOP

Yael L. Maxwell

July 08, 2015

News Daily News

Single-Center Study Adds Further Data to Debate Over PFO Closure

July 06, 2015

News Daily News

Un Estudio de un Único Centro Arroja Luz al Debate sobre el Cierre del FOP

July 06, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Daily News

RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional

June 25, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

News Industry News

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

June 18, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Yael L. Maxwell

June 17, 2015

News Daily News

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

May 14, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

La Trombosis Valvular Post-TAVR podría ser Más Habitual de lo que se Creía

L.A. McKeown

May 06, 2015

News Daily News

After Years of Scrutiny, Watchman Ready for Prime Time

April 03, 2015

News Daily News

Tras Años de Análisis, Watchman está Listo para Salir a Escena

April 03, 2015

News Industry News

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

March 24, 2015

News Industry News

Boston Scientific Receives FDA Approval for WATCHMAN™ Left Atrial Appendage Closure Device

March 13, 2015

Advertisement

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Los IAM secundarios a Embolismos Coronarios son Raros y Suelen Asociarse a la FA

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

A Mayor Edad, Mayor Riesgo de Isquemia Cerebral Recurrente en Pacientes sometidos al Cierre del FOP

Single-Center Study Adds Further Data to Debate Over PFO Closure

Un Estudio de un Único Centro Arroja Luz al Debate sobre el Cierre del FOP

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

La Trombosis Valvular Post-TAVR podría ser Más Habitual de lo que se Creía

After Years of Scrutiny, Watchman Ready for Prime Time

Tras Años de Análisis, Watchman está Listo para Salir a Escena

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

Boston Scientific Receives FDA Approval for WATCHMAN™ Left Atrial Appendage Closure Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content